Latest Articles
Marilyn Monroe and endometriosis: The hidden pain of a female icon - Soy Carmín
Marilyn Monroe and endometriosis: The hidden pain of a female icon Soy Carmín
Published: Aug. 5, 2026, 5:11 p.m.
What happened to Perez Hilton? Family issues statement on celebrity blogger's hospitalization - newscentermaine.com
What happened to Perez Hilton? Family issues statement on celebrity blogger's hospitalization newscentermaine.com
Published: Aug. 5, 2026, 4:33 p.m.
Georgia Woman Sues Kaiser Permanente Over False Cancer Diagnosis and Unnecessary Hysterectomy - Law Commentary
Georgia Woman Sues Kaiser Permanente Over False Cancer Diagnosis and Unnecessary Hysterectomy Law Commentary
Published: Aug. 5, 2026, 3:05 p.m.
Georgia Woman Sues Kaiser Permanente Over False Cancer Diagnosis and Unnecessary Hysterectomy - lawcommentary.com
Georgia Woman Sues Kaiser Permanente Over False Cancer Diagnosis and Unnecessary Hysterectomy lawcommentary.com
Published: Aug. 5, 2026, 3:05 p.m.
Baylen Dupree Confirms Endometriosis Diagnosis After Months of Uncertainty - jubileecast.com
Baylen Dupree Confirms Endometriosis Diagnosis After Months of Uncertainty jubileecast.com
Published: Aug. 5, 2026, 10:15 a.m.
Baylen Dupree Confirms Endometriosis Diagnosis After Months of Uncertainty - JubileeCast
Baylen Dupree Confirms Endometriosis Diagnosis After Months of Uncertainty JubileeCast
Published: Aug. 5, 2026, 10:15 a.m.
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval - Corsicana Daily Sun
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval Corsicana Daily Sun
Published: Aug. 4, 2026, 1:02 p.m.
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval - Voice of Alexandria
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval Voice of Alexandria
Published: Aug. 4, 2026, 1:02 p.m.
Sunshine Biopharma's 2mg Tablet for Endometriosis Pain Wins Canadian Approval - Stock Titan
Sunshine Biopharma's 2mg Tablet for Endometriosis Pain Wins Canadian Approval Stock Titan
Published: Aug. 4, 2026, 1 p.m.
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval - Benzinga
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval Benzinga
Published: Aug. 4, 2026, 12:31 p.m.
Link copied to clipboard!